Proto Labs (NYSE:PRLB) Releases Quarterly Earnings Results, Beats Expectations By $0.03 EPS

Proto Labs (NYSE:PRLB) posted its quarterly earnings results on Thursday. The industrial products company reported $0.63 EPS for the quarter, beating the consensus estimate of $0.60 by $0.03, FiscalAI reports. The business had revenue of $154.32 million during the quarter, compared to analyst estimates of $149.31 million. Proto Labs had a net margin of 5.44% and a return on equity of 4.80%. The company’s quarterly revenue was up 13.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.47 EPS.

Here are the key takeaways from Proto Labs’ conference call:

• Record third-quarter revenue rose 14.2% year over year to $154.3 million, marking the fourth consecutive quarter of double-digit growth. Adjusted EPS increased 33.4% to $0.63, while year-to-date adjusted EPS was up 45.5%.
• Management raised its full-year 2026 revenue growth outlook to 10%-11% from 8%-10%, implying the company’s first year of double-digit organic growth since 2018. Factory operations were especially strong, with CNC revenue up 16.7% and factory growth outpacing the Protolabs Network.
• Gross margin fell to 44.5% because of higher raw-material costs, machine upgrades, and temporary labor investments needed to support volume growth. Management expects fourth-quarter EPS of $0.46-$0.54, citing normal holiday seasonality, lower revenue, and higher operating expenses as a percentage of sales.
• Demand remains strong across aerospace, defense, space, drones, robotics, and data centers, while revenue per customer increased 17% as larger strategic customers expanded their relationships. The company is also investing in additional capacity, AI-enabled workflows, and operational capabilities, although Europe’s return to profitability remains a longer-term work in progress.

Proto Labs Price Performance

PRLB stock traded down $10.14 on Friday, hitting $67.50. 322,558 shares of the company were exchanged, compared to its average volume of 201,437. The stock has a market capitalization of $1.61 billion, a price-to-earnings ratio of 53.49 and a beta of 1.38. The business’s fifty day moving average is $86.47 and its two-hundred day moving average is $73.01. Proto Labs has a twelve month low of $45.10 and a twelve month high of $99.96.

Insider Buying and Selling

In other Proto Labs news, CFO Daniel Schumacher sold 5,000 shares of the firm’s stock in a transaction dated Thursday, September 24th. The shares were sold at an average price of $95.32, for a total value of $476,600.00. Following the transaction, the chief financial officer owned 35,019 shares of the company’s stock, valued at $3,338,011.08. This trade represents a 12.49% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 10,000 shares of company stock worth $902,629. Corporate insiders own 1.30% of the company’s stock.

Proto Labs News Summary

Here are the key news stories impacting Proto Labs this week:

• Positive Sentiment: Proto Labs reported third-quarter earnings of $0.63 per share, exceeding the $0.60 consensus estimate. Revenue rose 13.7% year over year to $154.32 million, also ahead of the $149.31 million analyst forecast. Proto Labs third-quarter financial results
• Positive Sentiment: Management raised its full-year 2026 earnings guidance, signaling confidence in profitability despite ongoing uncertainty in demand. The earnings improvement from $0.47 per share a year earlier further supports the positive operating trend. Proto Labs raises 2026 earnings guidance
• Neutral Sentiment: Proto Labs forecast fourth-quarter revenue of $143 million to $151 million. The range indicates continued business activity but would represent a sequential decline from third-quarter revenue, making the outlook important for investors assessing the pace of growth. Proto Labs fourth-quarter revenue outlook
• Negative Sentiment: Although the company beat quarterly estimates and lifted earnings guidance, the sequentially lower fourth-quarter revenue forecast may have disappointed investors seeking accelerating growth. With PRLB trading at a relatively high price-to-earnings ratio, strong results may already have been reflected in the stock, increasing the risk of profit-taking when the outlook is less robust than expected.

Analyst Ratings Changes

Several research analysts recently commented on PRLB shares. Wall Street Zen downgraded Proto Labs from a “strong-buy” rating to a “buy” rating in a research note on Saturday, July 18th. Zacks Research lowered shares of Proto Labs from a “strong-buy” rating to a “hold” rating in a research note on Friday, October 2nd. Cantor Fitzgerald restated an “overweight” rating on shares of Proto Labs in a report on Tuesday. Benchmark upped their price objective on Proto Labs from $70.00 to $91.00 and gave the stock a “buy” rating in a research report on Thursday, July 2nd. Finally, Needham & Company LLC increased their price target on shares of Proto Labs from $87.00 to $110.00 and gave the company a “buy” rating in a research note on Friday, October 23rd. Four analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $100.50.

About Proto Labs

Proto Labs, Inc (NYSE: PRLB), operating as Protolabs, is a digital manufacturing company that provides rapid prototyping and on-demand production services. The company uses automated quoting and manufacturing systems to help engineers and product developers produce custom parts without relying on traditional, lengthy tooling and procurement processes.

Protolabs offers computer numerical control (CNC) machining, injection molding, 3D printing and sheet-metal fabrication. Its services support the development and production of components in a range of materials and are used across industries including automotive, aerospace, medical, electronics and consumer products.

Founded in 1999 by entrepreneur Larry Lukis, the company has expanded its reach beyond its original U.S.